Targeting mTOR in Pancreatic Ductal Adenocarcinoma

Treatment options for advanced pancreatic ductal adenocarcinoma (PDAC) are limited; however, new therapies targeting specific tumor-related molecular characteristics may help certain patient cohorts. Emerging preclinical data have shown that inhibition of mammalian target of rapamycin (mTOR) in spec...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Main Authors: Iriana, Sentia, Ahmed, Shahzad, Gong, Jun, Annamalai, Alagappan Anand, Tuli, Richard, Hendifar, Andrew Eugene
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2016
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4843105/
https://ncbi.nlm.nih.gov/pubmed/27200288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2016.00099
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares